Schlafens: Emerging Therapeutic Targets
Cancers · 09.05.2024 · 16 (10) · 1805
DOI: 10.3390/cancers16101805 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 09.05.2024. Verfasst von Ricardo E Perez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH.
Abstract (Originalsprache)
The interferon (IFN) family of immunomodulatory cytokines has been a focus of cancer research for over 50 years with direct and indirect implications in cancer therapy due to their properties to inhibit malignant cell proliferation and modulate immune responses. Among the transcriptional targets of the IFNs is a family of genes referred to as Schlafens. The products of these genes, Schlafen proteins, exert important roles in modulating cellular proliferation, differentiation, immune responses, viral replication, and chemosensitivity of malignant cells. Studies have demonstrated that abnormal expression of various Schlafens contributes to the pathophysiology of various cancers. Schlafens are now emerging as promising biomarkers and potentially attractive targets for drug development in cancer research. Here, we highlight research suggesting the use of Schlafens as cancer biomarkers and the rationale for the development of specific drugs targeting Schlafen proteins.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA.
- Division of Hematology-Oncology, Department of Medicine, Northwestern University, Chicago, IL 60611, USA.
- Department of Medicine, Jesse Brown Veterans Affairs Medical Center, Chicago, IL 60612, USA.
ORCID-Profile: Ricardo E Perez, Frank Eckerdt
Förderung
- NCI NIH HHS
- NIH
Zitieren
APA
Perez, R. E., Eckerdt, F., & Platanias, L. C. (2024). Schlafens: Emerging Therapeutic Targets. Cancers, 16(10), 1805. https://doi.org/10.3390/cancers16101805
Vancouver
Perez RE, Eckerdt F, Platanias LC. Schlafens: Emerging Therapeutic Targets. Cancers. 2024;16(10):1805. doi:10.3390/cancers16101805
BibTeX
@article{Perez2024,
author = {Perez, Ricardo E and Eckerdt, Frank and Platanias, Leonidas C},
title = {Schlafens: Emerging Therapeutic Targets},
journal = {Cancers},
year = {2024},
volume = {16},
number = {10},
pages = {1805},
doi = {10.3390/cancers16101805}
}
EUVIMED